eXoZymes, Inc. (EXOZ) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Monrovia, NV, United States. The current CEO is Michael Heltzen.
EXOZ has IPO date of 2024-11-13, 31 full-time employees, listed on the NASDAQ Global Market, a market capitalization of $91.91M.
eXoZymes, Inc. operates as a synthetic biochemical company in the United States. The company develops SimplePath, a platform that produces chemicals, including pharmaceuticals, fuels, materials, food additives, and novel compounds. Its platform also comprises one or more module which consist of one or more enzymes that work together to perform a defined biocatalytic conversion. The company was founded in 2014 and is headquartered in Monrovia, California.
